LANCL2 antibody
Principal name
LANCL2 antibody
Alternative names for LANCL2 antibody
LANCL2, GPR69B, TASP, LanC-like protein 2, Testis-specific adriamycin sensitivity protein
Ncbi ID
9606, NP_061167, NP_061167.1, NP_598498.1, BC016072, NM_133737, NM_018697
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Flow Cytometry (F), Paraffin Sections (P)
Background of LANCL2 antibody
- Kit Component:
- - KN309127G1, Lancl2 gRNA vector 1 in pCas-Guide vector
- KN309127G2, Lancl2 gRNA vector 2 in pCas-Guide vector
- KN309127D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Immunofluorescence of purified MaxPab antibody to LANCL2 on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of LANCL2 expression in transfected 293T cell line (H00055915-T01) by LANCL2 MaxPab polyclonal antibody.Lane 1: LANCL2 transfected lysate(49.5 KDa).Lane 2: Non-transfected lysate.
LANCL2 MaxPab polyclonal antibody. Western Blot analysis of LANCL2 expression in A-431.
Immunofluorescence of purified MaxPab antibody to LANCL2 on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of LANCL2 expression in transfected 293T cell line (H00055915-T01) by LANCL2 MaxPab polyclonal antibody.Lane 1: LANCL2 transfected lysate(49.5 KDa).Lane 2: Non-transfected lysate.
LANCL2 MaxPab polyclonal antibody. Western Blot analysis of LANCL2 expression in A-431.
Human Placenta; WB Suggested Anti-LANCL2 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human Placenta; LANCL2 antibody - middle region (ARP57285_P050) in Human Placenta cells using Western Blot
Human Muscle; WB Suggested Anti-LANCL2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Human Muscle; LANCL2 antibody - middle region (ARP57286_P050) in Human Muscle cells using Western Blot
Immunohistochemical staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-LANCL2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800180)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-LANCL2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800180)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LANCL2 (RC209751, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LANCL2.
HEK293T cells transfected with either RC209751 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-LANCL2 antibody(TA800180), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-LANCL2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800249)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-LANCL2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800249)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LANCL2 (RC209751, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LANCL2.
WB Suggested Anti-LANCL2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: Human Muscle
WB Suggested Anti-LANCL2 Antibody Titration: 0.2-1 ug/ml; Positive Control: Human Placenta
Western blot analysis of LANCL2 in human brain tissue lysate with LANCL2 antibody at 1 ug/mL.
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA800180 | LANCL2 antibody |
||||||
| LANCL2 mouse monoclonal antibody, clone OTI2A11 (formerly 2A11) | |||||||
 |
Mouse | IgG1 | OTI2A11 | Purified | Hu | F, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
 +3 additional images |
Highly validated antibody!
|
||||||
| TA349203 | LANCL2 antibody |
||||||
| Rabbit Polyclonal Anti-LANCL2 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 mg /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA800249 | LANCL2 antibody |
||||||
| LANCL2 mouse monoclonal antibody, clone OTI1C5 (formerly 1C5) | |||||||
 |
Mouse | IgG1 | OTI1C5 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP309751 | LANCL2 |
||||
| Recombinant protein of human LanC lantibiotic synthetase component C-like 2 (bacterial) (LANCL2) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR207188L2V | Lenti ORF particles, Lancl2 (GFP-tagged) - Mouse LanC (bacterial lantibiotic synthetase component C)-like 2 (cDNA clone MGC:27554 IMAGE:4482042), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR217767L2V | Lenti ORF particles, Lancl2 (GFP-tagged) - Mouse LanC (bacterial lantibiotic synthetase component C)-like 2 (Lancl2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
| MR207188L1V | Lenti ORF particles, Lancl2 (Myc-DDK-tagged) - Mouse LanC (bacterial lantibiotic synthetase component C)-like 2 (cDNA clone MGC:27554 IMAGE:4482042), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
| MR217767L1V | Lenti ORF particles, Lancl2 (Myc-DDK-tagged) - Mouse LanC (bacterial lantibiotic synthetase component C)-like 2 (Lancl2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,000.00
|
|
| OriGene Technologies, Inc. | ||
